Evolution of the Average Target: Docebo Inc.

Evolution of the Target Price: Docebo Inc.

Changes in Analyst Recommendations: Docebo Inc.

4.YNlwy5qqUnYuEcgEVcPKbhinb8e5ddEl_kiN6_bKJG0.OogTsqPaFQJtJJJrNPqcX3rWGomPA4YVpD_6p4L-SRRW9B6x9psWNBhEvw~f8d63adcec96e91ca3c75d16c9d80073
23/04 CIBC Confirms Outperformer Rating and Target of US$28 on Docebo After Inspire 2026 Conference MT
22/04 Stifel Canada Sees Potential Upside For Docebo MT
17/04 CIBC Lowers Price Target on Software and Services Stocks MT
30/01 CIBC Confirms Outperformer Rating on Docebo and Raises Target to US$34.00 MT
22/01 Stifel Canada on Docebo Acquiring 365Talents MT
22/01 CIBC Maintained Its Outperformer Rating on Docebo As It Acquires 365Talents MT
16/12 CIBC's Top Picks For 2026 Software Sector MT
16/12 CIBC's Top Picks For 2026 Software Sector MT
07/11 Docebo Brief: Revising Financial Guidance for Fiscal Year ended December 31, 2025 MT
05/11 Oppenheimer Initiates Coverage on Docebo With Outperform Rating, CA$49.38 Price Target MT
09/25/09 Cantor Fitzgerald Initiates Docebo at Overweight With CA$47.85 Price Target MT
13/25/13 Docebo Shares Lower After Morgan Stanley Downgrade MT
12/25/12 Morgan Stanley Downgrades Docebo to Equalweight From Overweight After 'Disappointing' Q1 Update, Cuts Price Target to $32 From $41 MT
12/25/12 National Bank Downgrades Docebo to Sector Perform From Outperform, Adjusts Price Target to $35 From $45 MT
08/25/08 National Bank Says Docebo Promoting Farber to CFO is "Not Surprising" MT
03/25/03 Docebo Upgraded to Outperform at ATB MT
21/24/21 CIBC Raises Price Target on Six Software and Services Companies MT
13/24/13 Needham Adjusts Price Target on Docebo to $45 From $63, Keeps Buy Rating MT
19/24/19 Morgan Stanley Trims Price Target on Docebo to $65 From $67, Keeps Overweight Rating MT
26/24/26 Scotiabank Raises Docebo's Price Target to $65 From $60, Keeps Sector Outperform Rating MT
26/24/26 Morgan Stanley Adjusts Price Target on Docebo to $67 From $63, Keeps Overweight Rating MT
22/23/22 Morgan Stanley Boosts Price Target on Docebo to $63 From $53, Keeps Overweight Rating MT
23/23/23 Docebo Maintained at Buy at Stifel GMP Following C-Suite Changes; Price Target Raised to US$60.00 MT
14/23/14 Needham Starts Docebo With Buy Rating, Price Target is $56 MT
10/23/10 Goldman Sachs Raises Price Target on Docebo to $44 From $39, Maintains Neutral Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +28.14%
+14.72%
+7.99%
+20.45%
+25.26%
+36.63%
+30.36%
+22.89%
+12.55%
+4.33%
Average +20.33%
Weighted average by Cap. +15.01%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
24.64USD
Average target price
31.57USD
Spread / Average Target
+28.14%
High Price Target
31.57USD
Spread / Highest target
+28.14%
Low Price Target
31.57USD
Spread / Lowest Target
+28.14%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
  1. Stock Market
  2. Stocks
  3. DCBO Stock
  4. Consensus Docebo Inc.